The FDA approved the treatment in August, marking a significant advancement in the fight against lung cancer.

An experimental blood test detects early-stage pancreatic cancer more effectively than other available tests, reports a new study published in Cancer Letters.

In this study, the Cancer Research UK-funded scientists will establish the targets for the vaccine. They will find out which proteins on the surface of early-stage ovarian cancer cells are most strongly recognized by the immune system and how effectively the vaccine kills mini-models of ovarian cancer called organoids.

A world-first cancer vaccine could be in the hands of those with genetic indicators in the next five years, thanks to the pandemic

In new research, a team led by University of Cincinnati researchers has identified a potential new way to make radiation more effective and improve outcomes for patients with lung cancer that has spread to the brain.

LMU researchers have successfully tested a new drug which can significantly extend the lives of breast cancer patients.

If successful, the vaccine could protect women against ovarian cancer, which only around half of women survive long-term at the moment.

The vaccine is being developed by the University of Oxford

Scientists at the University of Oxford are creating OvarianVax, a vaccine which teaches the immune system to recognise and attack the earliest stages of ovarian cancer